INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES
批准号:
8357452
负责人:
Francois J Villinger
金额:
$4.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2012-04-30
关键词:
AnimalsAntiviral AgentsBlood TransfusionChronic PhaseEnsureExhibitsFundingFunding AgencyGammaretrovirusGeneticGrantHealthHumanImmune responseImmunizationInfectionInterferonsKineticsLeadLinkLymphoid TissueMacacaMacaca mulattaModelingNational Center for Research ResourcesOrganPathway interactionsPatientsPrimatesPrincipal InvestigatorProstateProstatic NeoplasmsProtocols documentationReagentResearchResearch InfrastructureResourcesRetroviridaeRoleSafetyScreening procedureSourceTestingUnited States National Institutes of HealthVascular blood supplyViralViremiaViruscostimmune activationin vivo Modelmanprogramsreproductivetooltransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The aims of this protocol are to document whether the human XMR virus is able to replicate in a model close to man, i.e. rhesus macaque. If XMRV is able to induce an active infection, what are the viral kinetics, dissemination and antiviral immune responses in this model. A strong correlation has established between the infection with a newly identified gammaretrovirus related to MuLV in prostate tumors from patients exhibiting a genetic inactivation of the RNASEL pathway (R462Q) linked to type I IFN antiviral mechanism. Thus, the hypothesis is that infection with the XMR virus in patients with a deficiency in the RNASEL or potentially other select innate antiviral pathway may lead to or at least contribute to rise of prostate tumors, especially in younger patients. This has obvious health program consequences including the potential for transmission via blood transfusion. This exploratory project will attempt to set up an in vivo model as well as generate reagents for use as screening tools for ensuring the safety of the blood supply. We have shown that XMRV induces a persistent clinically silent infection in rhesus macaques with very low viremia that may be reactivated following immunization/immune activation. Evidence for viral replication was also seen during the chronic phase in most reproductive organs and lymphoid tissues, suggesting likely transmission via sexual contact. This will be tested in new animals thanks to a new source of funding as well as the role of XMRV in the prostate in which early infection appears enriched.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expansion of Macaque Breeding runs at the New Iberia Research Center
-
批准号:10761902
-
项目类别:
-
资助金额:$399.91万
-
财政年份:2023
-
负责人:Francois J Villinger
-
依托单位:
Core D: Nonhuman Primates
-
批准号:10425029
-
项目类别:
-
资助金额:$152.77万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Nonhuman Primate Core
-
批准号:10460075
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Nonhuman Primate Core
-
批准号:10666570
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
“Renovation of Building 29 laboratories at the New Iberia Research Center"
-
批准号:10547926
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10797239
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Novel Macaque Breeding Runs at the New Iberia Research Center
-
批准号:10374603
-
项目类别:
-
资助金额:$350.65万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10409759
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10205548
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Non-Human Primate and Imaging Core
-
批准号:10224631
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2017
-
负责人:Francois J Villinger
-
依托单位:
Macque
-
批准号:8516869
-
项目类别:
-
资助金额:$135.62万
-
财政年份:2013
-
负责人:Francois J Villinger
-
依托单位:
BIOMARKERS ANALYSIS OF PREGNANT RHESUS MONKEYS
-
批准号:8357517
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
BIOLOGICAL MATERIAL PROCUREMENT PROGRAM
-
批准号:8357400
-
项目类别:
-
资助金额:$52.04万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS
-
批准号:8357386
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES
-
批准号:8357518
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
Macque
-
批准号:8198168
-
项目类别:
-
资助金额:$119.41万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
TH17 CELLS IN AIDS PATHOGENESIS AND HIV VACCINES
-
批准号:8357515
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates
-
批准号:8209669
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION
-
批准号:8357450
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
PD-1 MODULATION OF SIV SPECIFIC CD4 AND CD8 T CELL RESPONSES
-
批准号:8357513
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
海外基金